Pharmacy Daily | Panadol Choice – GSK

GLAXOSMITHKLINE (GSK) has responded to a report from Choice Magazine that Panadol Osteo and Panadol Back and Neck Long Lasting brands contained almost the same ingredients but that the latter was up to four times more expensive. GSK said both products had the same product formulation but managed different pain states. Panadol Osteo was for longer term pain and was listed on the Pharmaceutical Benefits Scheme, so its price was governed by government agreement, GSK said. “Panadol with Optizorb technology uses a unique combination of alginic acid and calcium carbonate to speed tablet disintegration and is clinically proven to be absorbed faster than regular Panadol tablets.” NPS MedicineWise Phone Line Services manager Sarah Spagnardi said it was possible for the action profile of analgesia to differ between two products with the same active ingredient and excipients if the tablet coating differed. However once absorbed into the bloodstream, a medicine exerted its action and therefore it was not possible for a medicine to target a particular part of the body, she said.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jun 14
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 14